Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by TechCrunch; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersChina's leading AI companies are ramping up the pressure on Silicon Valley, as Moonshot and Alibaba unveiled models they claim can go toe-to-toe with the best from OpenAI and Anthropic at a fraction of the cost. The rapi…
China's leading AI companies are ramping up the pressure on Silicon Valley, as Moonshot and Alibaba unveiled models they claim can go toe-to-toe with the best f…

Why it mattersFor the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Why it mattersSony Music Entertainment has filed another lawsuit against Udio, accusing the AI music generator of infringing the copyright of more than 30,000 of its songs, ranging from Elvis Presley's Hound Dog to Beyoncé's Say …
Sony Music Entertainment has filed another lawsuit against Udio, accusing the AI music generator of infringing the copyright of more than 30,000 of its songs, r…

Why it mattersAlphabet, Google's parent company, is reportedly working on a new chip designed to make its Gemini models run much more efficiently.